Vertex Pharmaceuticals Incorporated
VRTX · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 3, 2026 | — | 3.23B | — | 4.80 | — |
| 2026 Q1 | May 4, 2026 | 2.99B | 2.99B | 4.02 | 4.23 | -1.28% |
| 2025 Q4 | February 12, 2026 | 3.19B | 3.18B | 4.65 | 5.07 | +5.69% |
| 2025 Q3 | November 3, 2025 | 3.08B | 3.06B | 4.22 | 4.55 | -1.02% |
| 2025 Q2 | August 4, 2025 | 2.96B | 2.91B | 4.00 | 4.24 | -20.60% |
| 2025 Q1 | May 5, 2025 | 2.77B | 2.86B | 3.55 | 4.22 | -10.03% |
| 2024 Q4 | February 10, 2025 | 2.91B | 2.78B | 3.54 | 3.99 | -3.14% |
| 2024 Q3 | November 4, 2024 | 2.77B | 2.69B | 4.04 | 4.13 | +5.73% |
| 2024 Q2 | August 1, 2024 | 2.63B | 2.66B | -13.27 | -11.50 | -2.24% |
| 2024 Q1 | May 7, 2024 | 2.69B | 2.58B | 4.29 | 4.10 | +1.92% |
| 2023 Q4 | February 5, 2024 | 2.52B | 2.51B | 3.57 | 4.08 | -2.98% |
| 2023 Q3 | November 7, 2023 | 2.48B | 2.50B | 3.67 | 3.92 | -1.95% |
| 2023 Q2 | August 2, 2023 | 2.49B | 2.42B | 3.53 | 3.85 | +3.07% |
| 2023 Q1 | May 1, 2023 | 2.37B | 2.34B | 2.67 | 2.96 | +0.30% |
| 2022 Q4 | February 7, 2023 | 2.30B | 2.30B | 3.33 | 3.53 | -4.93% |
| 2022 Q3 | October 27, 2022 | 2.33B | 2.23B | 3.62 | 3.69 | +9.03% |